Shopping Cart
- Remove All
Your shopping cart is currently empty
Resolvin D2 (RvD2) is a lipid mediator biosynthesized by the sequential oxygenation of docosahexaenoic acid by 15- and 5-lipoxygenase. It evokes diverse anti-inflammatory effects which may mediate the resolution of inflammation. RvD2 methyl ester is a methyl ester version of the free acid which may act as a lipophilic prodrug form that will alter its distribution and pharmacokinetic properties. The methyl ester moiety is susceptible to cleavage by intracellular esterases, leaving the free acid.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 μg | $555 | 35 days | |
| 25 μg | $1,280 | 35 days | |
| 50 μg | $2,470 | 35 days | |
| 100 μg | $4,330 | 35 days |
| Description | Resolvin D2 (RvD2) is a lipid mediator biosynthesized by the sequential oxygenation of docosahexaenoic acid by 15- and 5-lipoxygenase. It evokes diverse anti-inflammatory effects which may mediate the resolution of inflammation. RvD2 methyl ester is a methyl ester version of the free acid which may act as a lipophilic prodrug form that will alter its distribution and pharmacokinetic properties. The methyl ester moiety is susceptible to cleavage by intracellular esterases, leaving the free acid. |
| Molecular Weight | 390.52 |
| Formula | C23H34O5 |
| Cas No. | 810668-53-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMF: 50 mg/mL (128.03 mM), Sonication is recommended. PBS (pH 7.2): 0.05 mg/mL (0.13 mM), Sonication is recommended. Ethanol: 50 mg/mL (128.03 mM), Sonication is recommended. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.